ATG-022

· Antengene Biologics Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATG-022, covering 2026-04-14 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]